Nureca's Financial Metrics Show Mixed Trends Amid Operational Gains and Challenges
Nureca, a microcap in the Medical Equipment sector, has recently adjusted its evaluation, reflecting changes in financial metrics. The company reported record net sales and operating profit in March 2025, indicating improved operational efficiency. However, challenges persist with declining sales growth and reliance on non-operating income.
Nureca, a microcap company in the Medical Equipment/Supplies/Accessories industry, has recently undergone an evaluation adjustment that reflects notable changes in its financial metrics. The latest assessment indicates a revision in its score, attributed to various underlying trends observed in its recent performance.In the quarter ending March 2025, Nureca reported its highest net sales at Rs 31.74 crore, alongside a peak in PBDIT of Rs 1.20 crore. The operating profit to net sales ratio also reached a notable 3.78%. These figures suggest a significant uptick in operational efficiency and revenue generation for the company during this period.
However, challenges remain evident, particularly with non-operating income constituting a substantial portion of profit before tax. Over the past five years, the company has experienced a decline in sales growth and EBIT, raising concerns about long-term sustainability.
The technical indicators present a mixed picture, with some metrics showing mildly bearish trends. Despite these complexities, Nureca's financial position reflects a low debt-to-equity ratio, which may provide some stability in a fluctuating market environment.
For more insights on Nureca's financial trends and performance, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
